Product |
Dose |
Package |
Caspofungin Acetate For Injection |
50mg |
1vials/box |
-
Caspofungin Acetate for Injection is a sterile powder containing caspofungin acetate, which inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall. It is formulated for intravenous administration and provides rapid onset of therapeutic effects.
Indications:
Caspofungin Acetate for Injection is indicated for the treatment of various invasive fungal infections, including:
Candidemia and invasive candidiasis: It is used as initial therapy for the treatment of candidemia and invasive candidiasis caused by Candida species.
Invasive aspergillosis: It may be employed in the management of invasive aspergillosis in patients who are refractory to or intolerant of other antifungal agents.
Esophageal candidiasis: It helps treat esophageal candidiasis, particularly in patients who cannot tolerate or have failed other antifungal therapies.
Dosage and Administration:
Caspofungin Acetate for Injection is reconstituted with sterile water for injection to form a solution for intravenous infusion. The dosage and administration schedule depend on factors such as the type and severity of the fungal infection, patient's weight, renal function, and treatment response. It is administered by a healthcare professional in a clinical setting, with close monitoring for adverse effects.
Precautions and Consultation:
Healthcare providers should assess the patient's medical history, concomitant medications, and risk factors before initiating treatment with Caspofungin Acetate for Injection. Patients with known hypersensitivity to caspofungin or other echinocandins should avoid its use. Close monitoring for adverse effects and therapeutic response is essential during treatment.